Recent

% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

  • valuestockinvestor2005 valuestockinvestor2005 Dec 1, 2004 10:01 AM Flag

    What's ELN's take on "oral" Antegren?

    We have yet to hear from them on this. I think if anyone can bring this to market, ELN would be at the forefront. Remember, natalizumab(Tysabri) was a product of ELN's Alzheimer's research, NOT BIIB's!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Oral Antegren is probably not possible because it is a complex protein antibody which would be quickly digested into fragments in the gut.

      A more realistic (and achievable) goal would be an injectable form of antegren, either IM or subcutaneous. Elan has considerable expertise in this area - I could see this happening - and approval would be realtively quick if there were no significant injection site effects - and dosing was achieved.

      Minn_sea...

 
ELN
0.0000(0.00%)